Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Molly L, Paras"'
Autor:
Marisa L. Winkler, Joanne Huang, Jessica Starr, David C. Hooper, Molly L. Paras, Alyssa R. Letourneau, Erica S. Shenoy
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 3 (2023)
Abstract Objective: Screening for asymptomatic bacteriuria (ASB) is not recommended outside of patients undergoing invasive urological procedures and during pregnancy. Despite national guidelines recommending against screening for ASB, this practice
Externí odkaz:
https://doaj.org/article/3a963685687448e7b4d894355108f37d
Autor:
Cormac M. Kinsella, Molly L. Paras, Sandra Smole, Samar Mehta, Vijay Ganesh, Lin H. Chen, Daniel P. McQuillen, Ruta Shah, Justin Chan, Matthew Osborne, Scott Hennigan, Frederic Halpern-Smith, Catherine M. Brown, Pardis Sabeti, Anne Piantadosi
Publikováno v:
Emerging Microbes and Infections, Vol 9, Iss 1, Pp 903-912 (2020)
ABSTRACTJamestown Canyon virus (JCV) is a neuroinvasive arbovirus that is found throughout North America and increasingly recognized as a public health concern. From 2004 to 2012, an average of 1.7 confirmed cases were reported annually in the United
Externí odkaz:
https://doaj.org/article/c40367d46aa2489094bc6b641573f610
Autor:
Natalie J Atallah, Hailey M Warren, Matthew B Roberts, Ramy H Elshaboury, Monique R Bidell, Ronak G Gandhi, Meagan Adamsick, Maryam K Ibrahim, Rupali Sood, Savo Bou Zein Eddine, Matthew J Cobler-Lichter, Natalie J Alexander, Kyle D Timmer, Christine J Atallah, Adam L Viens, Vahe S Panossian, Allison K Scherer, Teddie Proctor, Sherrie Smartt, Alyssa R Letourneau, Molly L Paras, Sascha Johannes, Jan Wiemer, Michael K Mansour
Publikováno v:
PLoS ONE, Vol 17, Iss 1, p e0262342 (2022)
PurposeCoronavirus disease-2019 (COVID-19) is associated with a wide spectrum of clinical symptoms including acute respiratory failure. Biomarkers that can predict outcomes in patients with COVID-19 can assist with patient management. The aim of this
Externí odkaz:
https://doaj.org/article/40caa49471e94ffe9ec4277313441df5
Autor:
Ramy H. Elshaboury, Miranda M. Monk, Lisa M. Bebell, Monique R. Bidell, Meagan L. Adamsick, Ronak G. Gandhi, Molly L. Paras, Elizabeth L. Hohmann, Alyssa R. Letourneau
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 8 (2021)
Background: Remdesivir (RDV) was approved for treatment of coronavirus disease 2019 (COVID-19), in May 2020 under US Food and Drug Administration emergency use authorization (EUA). Clinical outcomes related to RDV use in hospitalized patients during
Externí odkaz:
https://doaj.org/article/57068c974cd34edb8ffb123e84ce18bb
Autor:
Vera P Luther, Alice E Barsoumian, Victoria JL Konold, Tara Vijayan, Gayle Balba, Constance Benson, Brian Blackburn, Paloma Cariello, Sarah Perloff, Raymund Razonable, Kartikey Acharya, Marwan M Azar, Nitin Bhanot, Dana Blyth, Saira Butt, Beata Casanas, Brian Chow, Kerry Cleveland, James B Cutrell, Saumil Doshi, Diana Finkel, Christopher J Graber, Aniruddha Hazra, Natasha S Hochberg, Scott H James, Anna Kaltsas, Rosy Priya L Kodiyanplakkal, Mikyung Lee, Luis Marcos, Alfredo J Mena Lora, Christopher C Moore, Obina Nnedu, Georgina Osorio, Molly L Paras, Rebecca Reece, Natalie Mariam Salas, Kamla Sanasi-Bhola, Sara Schultz, Jose A Serpa, Rachel Shnekendorf, Scott Weisenberg, Darcy Wooten, Richard A Zuckerman, Michael Melia, Lisa M Chirch
Publikováno v:
Open forum infectious diseases, vol 10, iss 6
The Infectious Diseases Society of America (IDSA) has set clear priorities in recent years to promote inclusion, diversity, access, and equity (IDA&E) in infectious disease (ID) clinical practice, medical education, and research. The IDSA IDA&E Task
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebca43d05e2d73fd90b9ed43d84e0316
https://escholarship.org/uc/item/7064618m
https://escholarship.org/uc/item/7064618m
Autor:
Molly L Paras
Publikováno v:
Clinical Infectious Diseases.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66dff06af4bdf92fb43a7b7ec3d6db5a
https://doi.org/10.1093/cid/ciad269
https://doi.org/10.1093/cid/ciad269
Autor:
Evin Yucel, Benjamin Bearnot, Molly L. Paras, Emily K. Zern, David M. Dudzinski, Chen-Pang Soong, Arminder S. Jassar, Kenneth Rosenfield, Jaclynne Lira, Eugene Lambert, Sarah E. Wakeman, Thoralf Sundt
Publikováno v:
Journal of the American College of Cardiology. 79:2037-2057
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8448b37e119c2c6ce57ab2128c3a5c8a
https://doi.org/10.1016/j.jacc.2022.03.349
https://doi.org/10.1016/j.jacc.2022.03.349
Autor:
Molly L. Paras, Shaan Khurshid, Borek Foldyna, Alex L. Huang, Elizabeth L. Hohmann, Leslie T. Cooper, Bianca B. Christensen
Publikováno v:
New England Journal of Medicine. 386:1647-1657
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce6adf0520f97e9fa9273388c64966fe
https://doi.org/10.1056/nejmcpc2201233
https://doi.org/10.1056/nejmcpc2201233
Autor:
Marisa Winkler, Joanne Huang, Jessica Starr, Molly L Paras, Alyssa R Letourneau, David Hooper, Erica S Shenoy
Publikováno v:
Open Forum Infectious Diseases. 9
Background Despite national guidelines from the US Preventative Services Task Force and the Infectious Diseases Society of America that recommend against screening for asymptomatic bacteriuria (ASB, defined as > 105 CFU of an organism) in most circum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20ac6ce1cb10033388b6505875aca27d
https://doi.org/10.1093/ofid/ofac492.237
https://doi.org/10.1093/ofid/ofac492.237
Autor:
Molly L, Paras, Arminder S, Jassar
Publikováno v:
Journal of the American Society of Echocardiography. 35:576-578
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a217a37463e6387c194c5e15cd153b6e
https://doi.org/10.1016/j.echo.2022.02.007
https://doi.org/10.1016/j.echo.2022.02.007